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Background: Due to the recent European legislations posing a ban of animal tests for safety assessment within the
cosmetic industry, development of in vitro alternatives for assessment of skin sensitization is highly prioritized. To
date, proposed in vitro assays are mainly based on single biomarkers, which so far have not been able to classify
and stratify chemicals into subgroups, related to risk or potency.
Methods: Recently, we presented the Genomic Allergen Rapid Detection (GARD) assay for assessment of chemical
sensitizers. In this paper, we show how the genome wide readout of GARD can be expanded and used to identify
differentially regulated pathways relating to individual chemical sensitizers. In this study, we investigated the
mechanisms of action of a range of skin sensitizers through pathway identification, pathway classification and
transcription factor analysis and related this to the reactive mechanisms and potency of the sensitizing agents.
Results: By transcriptional profiling of chemically stimulated MUTZ-3 cells, 33 canonical pathways intimately involved
in sensitization to chemical substances were identified. The results showed that metabolic processes, cell cycling and
oxidative stress responses are the key events activated during skin sensitization, and that these functions are engaged
differently depending on the reactivity mechanisms of the sensitizing agent. Furthermore, the results indicate that
the chemical reactivity groups seem to gradually engage more pathways and more molecules in each pathway with
increasing sensitizing potency of the chemical used for stimulation. Also, a switch in gene regulation from up
to down regulation, with increasing potency, was seen both in genes involved in metabolic functions and cell
cycling. These observed pathway patterns were clearly reflected in the regulatory elements identified to drive these
processes, where 33 regulatory elements have been proposed for further analysis.
Conclusions: This study demonstrates that functional analysis of biomarkers identified from our genomics study of
human MUTZ-3 cells can be used to assess sensitizing potency of chemicals in vitro, by the identification of key cellular
events, such as metabolic and cell cycling pathways.
Keywords: Pathways in skin sensitization, Skin sensitizer, in vitro assay, Signaling pathways, Metabolic pathwaysBackground
Allergic contact dermatitis (ACD) is an inflammatory
skin disease characterized by eczema and recurrent epi-
sodes of itching [1]. Hundreds of chemicals are known
to cause skin sensitization, making ACD the most com-
mon immunotoxic condition in humans. ACD affects a
significant proportion of the population. In a recent* Correspondence: ann-sofie.albrekt@immun.lth.se
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reproduction in any medium, provided the orpopulations-based investigation, it was demonstrated
that the prevalence of ACD is increasing, from 7.2% to
12.9% in the study population [2]. According to the
REACH (Registration, Evaluation, and Authorization of
Chemicals) regulation [3], chemicals within the EU that
are produced or imported (>1 ton/year) must be tested
for human hazardous effects. Historically, new chemicals
have been tested on animals. For cosmetic ingredients,
animal testing is now prohibited [4], even if validated
alternative assays are unavailable.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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currently the gold standard in hazard classification for
sensitization, has been shown to have an accuracy of
prediction of 72% relative to human data, the same as
for the Guinea Pig Maximization Test (GPMT) [6].
Taken together, the ethical aspects of animal testing, the
need for monitoring of hazardous effects and the dis-
crepancy between animal and human immune mecha-
nisms makes the need for in vitro tests urgent.
Recently, we presented an in vitro test, Genomic
Allergen Rapid Detection (GARD), based on MUTZ-3
cells [7,8], that was able to accurately classify compounds
as sensitizers or non-sensitizers, using a genomic bio-
marker signature [9,10]. Furthermore, we reported that
sensitizers induced a heterogeneous transcriptional re-
sponse in MUTZ-3 cells, indicating that different sensi-
tizers affect different pathways. The OECD guidelines on
adverse outcome pathways [11] attempts to summarize
the biochemical pathways that are associated with skin
sensitization, listing the activation of inflammation and
cellular stress related pathways as critical events. How-
ever, transcriptional data from MUTZ-3 cells indicate
that the regulation of biochemical pathways might be
more diverse than previously described. This led us to
further investigate the signaling pathways in relationship
to the chemical reactivity properties of each individual
skin sensitizer. Consequently, the aim of the current
study was to identify adverse outcome pathways associ-
ated with different sensitizers, stratified into various
chemical reactivity groups, in order to enhance the under-




A panel of 40 chemical compounds, consisting of 20
sensitizers and 20 non-sensitizers were used for cell
stimulations of the human myeloid leukemia-derived cell
line MUTZ-3 (DSMZ, Braunschweig, Germany), as de-
tailed earlier in [10]. RNA was isolated, processed to
cDNA and hybridized to microarrays (Affymetrix®, Santa
Clara, CA) [12]. In short, RNA from un-stimulated and
chemically stimulated MUTZ-3 cells, from triplicate
experiments, were extracted and analyzed. The prep-
aration of labeled sense DNA was performed, according
to Affymetrix® GeneChip® Whole Transcript (WT) Sense
Target Labeling Assay (100 ng Total RNA Labeling
Protocol), using the recommended kits and controls
(Affymetrix®). Hybridization, washing and scanning of
the Human Gene 1.0 ST Arrays were performed accord-
ing to the manufacturer’s protocol (Affymetrix®). 18 of
the 20 sensitizing chemicals [13-18] passed QC test after
array analysis and were subsequently used for functional
analysis (Figure 1). The complete data set consisting of137 samples has been deposited to ArrayExpress with the
accession number [E-MTAB-670].
Microarray data analysis and statistical methods
The microarray data set was normalized and quality
checked, using the RMA algorithm in the Affymetrix®
Expression Console software (Affymetrix®). Sensitizers
were assigned to at least one of the following chemical
reactivity mechanisms; addition/elimination to carboxylic
acid derivatives (Add/El), coordination bonds (Koor),
Michael addition or 1,4-addition to a/b unsaturated car-
bonyl (MA), nucleophilic aromatic substitution (NAR),
Schiff ’s base reaction (SB), biomolecular nucleophilic sub-
stitution (SN2), Prehapten (PreH) and Prohapten (ProH).
In the present cohort of sensitizers, 9 different groups of
chemical reactivity combinations were identified, as shown
in Figure 1. The 9 reactivity groups were statistically tested
against a pool of non-sensitizing stimulations and vehicle
controls (83 samples in total), using ANOVA. The top
1000 genes from each statistical test were identified, and
the significance level at which these top genes were found
was recorded. All filtering and statistical tests were per-
formed in Qlucore Omics Explorer 2.3 (QOE; Qlucore AB,
Lund, Sweden).
Functional analysis of chemical reactivity groups in IPA®
Each of the 9 gene lists identified with statistical testing
was used as input in Ingenuity Pathways Analysis ver.
12710793, as of June 2012 (IPA®; Ingenuity Systems Inc.,
Redwood City, CA), using fold change and p-values as
decision values for significance and enrichment calcula-
tions. For each data set the significant canonical path-
ways, significant transcription regulators and cellular
functions identified by IPA® Core Analysis of Human
data using default settings were exported and analyzed
further in QOE. Hierarchical Cluster Analysis (HCA)
was performed using non-normalized data with max-
imum linkage.
Pathway annotation and grouping for assessment of
biological functions
All pathways were named according to the terminology
used by IPA®. In addition to pathway names, we also
grouped pathways into functional groups, according to
the grouping used by IPA® (apoptosis signaling, cell cycle
regulation etc.) with all pathways being classified as
either signaling or metabolic pathways or both. When a
pathway was ambiguously assigned we chose the first
listing, according to alphabetical order. Findings were
confirmed, using MetaCore™ (Thomson Reuters, NY).
Availability of supporting data
The microarray data set used was deposited at Array
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Potassium dichromate Extreme [14]
Oxazolone2 Extreme [13]














Cinnamic alcohol Weak [17]
Eugenol Weak [16]
Penicillin G Weak [16]
Figure 1 Stratification of chemical sensitizers into reactive mechanism groups. 1) Black: classification generally acknowledged. Grey: possibly
ambiguous classification. 2) Indicated stimulations did not pass QC tests and were removed from analysis. Chemical reactivity abbreviations: Add/El:
Addition/elimination to carboxylic acid derivatives; Koor: Coordination bonds; MA: Michael addition or 1,4-Addition to a/b unsaturated carbonyl; NAR:
nucleophilic aromatic substitution, PreH: Prehapten; Chemical activation (outside the skin); ProH: Prohapten; Enzymatic activation; SB: Schiff’s Base
reaction; SN2: bimolecular nucleophilic substitution.
Albrekt et al. BMC Pharmacology and Toxicology 2014, 15:5 Page 3 of 12
http://www.biomedcentral.com/2050-6511/15/5Results and discussion
MUTZ-3 transcriptional profiling and stratification of
sensitizers into chemical reactivity groups
The transcriptome of MUTZ-3 cells stimulated with skin
sensitizers and non-sensitizers was analyzed, using DNA
microarray technology, with triplicate samples of 40 in-
dividual stimulations [10]. Due to insufficient array qual-
ity, 2 out of 20 sensitizers were removed from further
analysis, leaving 18 triplicates of sensitizers and 20 tripli-
cates of non-sensitizers for analysis in this study. The
relationship between the sensitizers’ potency, according
to the Local Lymph Node Assay, and the designation of
these into different chemical reactivity groups are sum-
marized in Figure 1.
A Principal Component Analysis (PCA) analysis of the
complete expression data set visualized that the studied
chemical reactivities were indeed quite distinct, as
shown in Figure 2. Though there is a certain overlap be-
tween the groups there are also clear differences, which
is a strong indicator that the 9 chemical groups may trig-
ger different biological activities, while the effects of non-
sensitizing samples are homogenous. The PCA plot in
Figure 2 was based on the 26 most significant genes in
the data set from an ANOVA, comparing sensitizers with
non-sensitizers. However, the observed pattern is clearly
visible also in the complete data set, where no statistical
test has guided the PCA. To further ensure that this
is a biological finding, randomization and permutation of
data was performed, comparing the original data set to
randomized and permuted data sets. Statistical significancewas only found in the original data set, which shows that
the observed patterns are not seen due to random effects
in multidimensional data.
The apparent differences in transcriptional profiles
among different reactivity groups led us to further ex-
plore the differential engagement of signaling and meta-
bolic pathways and the upstream regulators initiating
such pathways. To this end, each chemical reactivity
group was compared to the set of non-sensitizers in an
ANOVA, yielding 9 lists of differentially regulated genes.
These 9 gene lists were subsequently imported into IPA®
for further analysis.
Using the Core Analysis of the pathway software IPA®,
a number of regulated pathways were identified. In total,
387 regulated pathways were detected in the 9 different
chemical reactivity groups. By applying a cut-off of three
times, the default IPA® significance (−log(p-value) ≤ 3.9),
33 pathways were selected for a comprehensive investi-
gation. The differential engagement patterns of the 33
pathways, related to sensitizer reactivity, are summarized
in Figure 3, and detailed in Additional file 1. In addition,
Figures 4 and 5 indicate the direction of regulation, as
well as the level of significance at which the IPA® input
gene lists were identified. When studying the 33 selected
pathways, it is evident that increasing potency correlates
with enhanced pathway involvement in terms of number
of regulated genes, as well as a shift towards down regu-
lation of the pathways components.
Finally, to identify the drivers in relation to potency,
analysis of upstream regulators was performed. In Figure 3,
Figure 2 Principal component analysis (PCA) plot of sensitizers
and non-sensitizers. The PCA plot shows the 26 most significant
genes, based on p-value from an ANOVA comparing sensitizers
with non-sensitizers. Triplicate samples of 18 sensitizers and 20
non-sensitizers are shown. The coloring shows the different chemical
reactivity groups included. The sensitizers are centered in the
top of the plot and the non-sensitizers in the bottom of the
plot. Add/El: Addition/elimination to carboxylic acid derivatives; Koor:
Coordination bonds; MA: Michael addition or 1,4-Addition to a/b
unsaturated carbonyl; NAR: nucleophilic aromatic substitution, PreH:
Prehapten; Chemical activation (outside the skin); ProH: Prohapten;
Enzymatic activation; SB: Schiff’s Base reaction; SN2: bimolecular
nucleophilic substitution.
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summarized. The significance calculations include a pre-
dicted activation or inhibition status, which takes regula-
tion of connected molecules into account. Only upstream
regulators predicted to be significantly up or down regu-
lated in four or more chemical groups were reported
here. The regulatory elements were studied for their rela-
tionship to each other, using the MetaCore™ database.
These findings were summarized in Figure 6. A complete
list of all regulatory elements predicted is found in the
Supplementary materials (Additional file 2).Prominent pathways and biological functions
The overall impression is that more genes, associated
with various pathways, are down-regulated than up-
regulated in MUTZ3 cells stimulated with sensitizers.
The sensitizers act mainly on cell cycling, cellular stress
and injury, and metabolic pathways, in that order. Rele-
vant identified sub functions are apoptosis, cellular
growth and development, cellular immune response,
intracellular and second messenger signaling, and metab-
olism and biosynthesis of glycan, lipids, vitamins and co-
factors and nucleotides. The general trend is that both
metabolic and cell cycle associated pathways are engaged
gradually and in correlation with potency. Oxidative
stress related pathways are another group of highly en-
gaged pathways. However, these do not correlate with po-
tency in the same manner as the other pathways do. For
example, the NRF2-mediated oxidative stress response
pathway shows a reversed pattern compared to the other
pathways presented in this study. The overall impression
of the NRF2 pathway is that phase I and II enzymes, as
well as antioxidant proteins, are up-regulated, for an
example see Additional file 3. While these trends are
quite weak we still think it deserves further investiga-
tion. Pathways regulating metabolism and biosynthesis
processes are regulated to a lesser extent but still show
the same pattern as seen in the cell cycling pathways.
Finally, we report 33 potential key regulators of the skin
sensitization process found in the analyses. For a
complete list of pathways and regulation patterns see
Figures 3, 4, and 5. One more pathway has a pattern
similar to the one observed in NRF2-mediated oxidative
stress response pathway, namely Sphingolipid metabol-
ism. The less potent chemical reactivity groups seem to
engage this pathway to a larger extent than the more po-
tent ones.
A few metabolic pathways are generally regulated.
These are the nucleotide and lipid metabolism pathways.
Chemicals belonging to the nucleophilic aromatic substi-
tution (NAR) and coordination bonds (Koor) group
down regulate nucleotide metabolism the most. As the
current chemical selection includes only highly potent
sensitizers from the Koor and NAR group, we cannot
extrapolate these findings to less potent ones. Also, the
NAR group constitutes a somewhat odd case, since this
is a small group of highly experimental allergens with
limited clinical relevance. The other metabolic pathways
are regulated in a more mixed fashion, but again, amino
acid metabolism is gradually down-regulated with in-
creasing chemical potency. The Glutathione metabolism
pathway is interesting in that it goes from clear up regu-
lation by the less potent chemicals to clear down regula-
tion by the NAR group. While the division of pathways
into signaling or metabolic pathways is a somewhat arbi-
trary matter, we still believe it reflects the major cellular
Figure 3 Hierarchical cluster analysis of pathway and regulatory elements. This hierarchical cluster analysis shows the regulatory elements
predicted to have a general activity in the data set, i.e. in at least 4 of the 9 groups. Regulatory elements are colored according to the activation
state. Red color indicates activation, while green color indicates inhibition. Dark and pale red/green colors indicate high and low significance of
change, respectively. 33 pathways were found to be significantly regulated by the chemicals. These were clustered and colored from white to
blue according to the involvement grade of the pathway, as estimated by the number of regulated molecules. The chemical groups were
ordered according to their Local Lymph Node Assay potency with the most potent to the left and least potent to the right in the picture. The
complete data set is given in Additional file 1.
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ard [19] at the time, adopted from the IPA® software.
The pathways of cell cycle regulation are also gradually
down-regulated with increasing potency. This could in-
dicate that these chemicals induce cell cycle arrest. As
discussed later this seems to be connected to activation
state of the up-stream regulators identified in the ana-
lyses, especially the let-7 microRNAs.The apoptosis pathway Aryl hydrocarbon receptor
(AHR) signaling is also among the frequently regulated.
As seen from Figure 3, its usage does increase with po-
tency, but the base level is among the highest observed.
Several caspases in the AHR signaling are highly up-
regulated by many of the chemical groups. Caspases are
both involved in cell death processes, like cell shrinkage,
membrane blebbing, DNA fragmentation and DNA repair,
Pathway group (IPA®) Signaling pathway1
Chemical reactivity group
NAR Koor MA+Add/El SB ProH SN2 MA
ProH+
PreH Add/El
Apoptosis Aryl hydrocarbon receptor signaling ↓ ↓ MIX MIX MIX MIX MIX MIX MIX
Cancer
Role of BRCA1 in DNA damage 
response ↓ ↓ ↓ ↓ MIX ↓ MIX ↓ (↑)
Hereditary breast cancer signaling ↓ ↓ ↓ ↓ MIX MIX MIX MIX ↓
p53 signaling MIX MIX MIX MIX MIX MIX MIX MIX ↓
Cell cycle regulation
Cell cycle control of chromosomal 
replication ↓ ↓ ↓ ↓ (↓) ↓ (↓) (↓) (↑)
Mitotic role of polo-like kinases ↓ ↓ ↓ ↓ ↓ ↓ ↑ MIX (↓)
Cyclins and cell cycle regulation ↓ ↓ MIX ↓ MIX ↓ MIX (↓) ↓
Estrogen-mediated S-phase entry ↓ ↓ MIX ↓ MIX ↓ MIX (↓) (↓)
Cell cycle : G2/M DNA damage 
checkpoint regulation
↓ MIX ↓ ↓ MIX ↓ ↑ (MIX) (MIX)
Cell cycle: G1/S checkpoint regulation ↓ ↓ MIX ↓ MIX ↓ MIX (↓) ↓
GADD45 signaling ↓ MIX MIX ↓ MIX (MIX) (MIX) (↑) (↓)
Role of CHK proteins in cell cycle 
checkpoint control
↓ ↓ ↓ ↓ MIX MIX MIX ↓ (↓)
ATM signaling ↓ ↓ ↓ ↓ ↑ MIX ↑ (MIX) (MIX)
Cellular growth, proliferation 
and development
RAN signaling ↓ (↓) (↓) ↓ ↓ (↓) (↓) ↓ (↓)
PDGF Signaling MIX MIX MIX MIX MIX ↓ MIX MIX ↑
Antigen presentation pathway (↓) NC MIX (↑) (↑) ↓ ↑ (↑) (↑)
Cellular immune response
Granzyme A signaling (↓) (↓) ↓ ↓ ↓ (↓) (↓) ↓ (↓)
Cytotoxic T lymphocyte mediated 
apoptosis of target cells
(MIX) MIX MIX (↑) MIX ↓ ↑ (MIX) (↑)
Altered T cell and B cell signaling in 
rheumatroid arthritis
(↑) (↑) MIX (↑) ↑ MIX MIX (↓) (MIX)
Granzyme B signaling MIX MIX (MIX) MIX MIX ↓ (MIX) (↓) NC
Cellular stress and injury
NRF2-mediated oxidative stress 
response ↓ ↓ MIX MIX MIX MIX ↑ MIX MIX
Mismatch repair in eukaryotes ↓ ↓ ↓ ↓ NC (↓) (MIX) (↓) NC
p-value cut-off for 1000* best genes 8e-9 8e-14 5e-4 3e-3 4e-6 2e-4 2e-4 3e-4 3e-3
q-value cut-off for 1000* best genes 2e-7 2e-12 2e-2 10e-2 1e-4 5e-3 4e-3 8e-3 9e-2
Figure 4 Signaling pathways identified to be significantly regulated. The figure shows signaling pathways and general regulation patterns
observed in these, as identified by analysis of each chemical reactivity group. Chemical reactivity abbreviations: Add/El: Addition/elimination to
carboxylic acid derivatives; Koor: Coordination bonds; MA: Michael addition or 1,4-Addition to a/b unsaturated carbonyl; NAR: nucleophilic
aromatic substitution, PreH: Prehapten; Chemical activation (outside the skin); ProH: Prohapten; Enzymatic activation; SB: Schiff’s Base reaction;
SN2: bimolecular nucleophilic substitution. * most significant genes in t-test of negative samples versus given chemical reactivity group. 1) Only
pathways where at least one group gives a contribution of 2 times the significance threshold from IPA® were reported. ↑: 80% of transcripts or
more up regulated, regulated transcripts ≥5. (↑): 80% of transcripts or more up regulated, regulated transcripts <5. ↓: 80% of transcripts or more
down regulated, regulated transcripts ≥5. (↓): 80% of transcripts or more down regulated, regulated transcripts <5. MIX: a mix of up and down
regulation, regulated transcripts ≥5. (MIX): a mix of up and down regulation, regulated transcripts <5. NC: No significant change compared
to non-sensitizers.
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Lysine biosynthesis (↓) (↓) NC (↓) (MIX) ↓ (↑) (↓) NC
Valine, Leucine and Isoleucine 
biosynthesis (↓) ↓ (↓) (↓) (↓) (↓) NC (↓) (MIX)
Valine, Leucine and Isoleucine 
degradation ↓ ↓ ↓ (↓) MIX ↓ MIX (↓) (↑)
Methionine metabolism NC ↓ (↓) (↓) ↓ (↓) (MIX) (MIX) NC
Aminoacyl-tRNA biosynthesis ↓ ↓ (↓) NC ↓ ↓ (↑) ↓ (↓)
Glutathione metabolism ↓ (MIX) (MIX) (MIX) ↑ (MIX) MIX ↑ (↑)
Glycan Bio-synthesis and 
Metabolism Glycosaminoglycan degradation NC NC (↑) (↑) (↑) NC MIX (↑) NC
Lipid metabolism Sphingolipid metabolism MIX MIX MIX MIX ↑ MIX MIX MIX ↓
Metabolism of cofactors 
and vitamins One carbon pool by folate ↓ ↓ ↓ ↓ ↓ ↓ NC (↓) NC
Nucleotide metabolism
Pyrimidine metabolism ↓ ↓ MIX ↓ MIX MIX MIX ↓ MIX
Purine metabolism ↓ ↓ MIX ↓ MIX ↓ MIX ↓ MIX
p-value cut-off for 1000* best genes 8e-9 8e-14 5e-4 3e-3 4e-6 2e-4 2e-4 3e-4 3e-3
q-value cut-off for 1000* best genes 2e-7 2e-12 2e-2 10e-2 1e-4 5e-3 4e-3 8e-3 9e-2
Figure 5 Metabolic pathways identified to be significantly regulated. The figure shows metabolic pathways and general regulation patterns
observed in these, as identified by analysis of each chemical reactivity group. Chemical reactivity abbreviations: Add/El: Addition/elimination to
carboxylic acid derivatives; Koor: Coordination bonds; MA: Michael addition or 1,4-Addition to a/b unsaturated carbonyl; NAR: nucleophilic aromatic
substitution, PreH: Prehapten; Chemical activation (outside the skin); ProH: Prohapten; Enzymatic activation; SB: Schiff’s Base reaction; SN2: bimolecular
nucleophilic substitution. * most significant genes in t-test of negative samples versus given chemical reactivity group. 1) Only pathways
where at least one group gives a contribution of 2 times the significance threshold from IPA® were reported. ↑: 80% of transcripts or more up regulated,
regulated transcripts ≥5. (↑): 80% of transcripts or more up regulated, regulated transcripts <5. ↓: 80% of transcripts or more down regulated, regulated
transcripts ≥5. (↓): 80% of transcripts or more down regulated, regulated transcripts <5. MIX: a mix of up and down regulation, regulated transcripts ≥5.
(MIX): a mix of up and down regulation, regulated transcripts <5. NC: No significant change compared to non-sensitizers.
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tein degradation and synthesis [20]. There are also connec-
tions between apoptosis and cell cycle regulators. Caspase
6, for example, is known to interact directly with the tran-
scription factor Rb [21], which is a key regulator of the Cell
Cycle Control of Chromosomal Replication pathway. As
described previously, a shift towards down regulation of
pathway members is observed with increasing potency. For
a detailed list of the molecules in the AHR signaling path-
way, see Additional file 4.
Finally, lipid metabolism is generally affected by all the
chemical groups. For instance, addition/elimination to
carboxylic acid derivatives (Add/El) clearly down regu-
lates Sphingolipid metabolism and the remaining chem-
ical groups show a mixed or up-regulated pattern.
Biological activity of specific chemical groups
From the pathway analysis it is clear that various chemical
reactivity groups stimulate pathway activation or inhibitiondifferentially. This selective effect is e.g. observed for chemi-
cals of the Michael addition or 1,4-Addition to a/b unsatur-
ated carbonyl (MA) group, which up regulate several of the
signaling pathways, as well as chemicals of the addition/
elimination to carboxylic acid derivatives (Add/El). The
groups prehapten (Chemical activation outside the skin;
PreH) + prohapten (enzymatic activation; ProH) and Add/
El (addition/elimination to carboxylic acid derivatives) both
show a very limited activity in most pathways studied.
Considering the activity levels and changes of tran-
scription observed and summarized in Figures 3, 4,
and 5, we conclude that there is no single mechanism
of action of skin sensitizing chemicals. On the contrary,
a range of functions are triggered at different levels by
the studied chemical groups. Some chemical groups,
notably the most potent ones, down regulate most or
all pathways studied. Others, like MA, up regulate
relatively many pathways, while e.g. addition/elimination
to carboxylic acid derivatives (Add/El) and prohapten +
Figure 6 Network of interactions between transcription regulators observed or predicted in the IPA® analysis of the 9 chemical
reactivity groups. Observed expression patterns were analyzed using IPA® in order to predict upstream regulation. The prediction was based on
the expression patterns of the chemical groups and only the most significant predictions were included here. The network shows the known
interactions between the regulatory elements identified to be up or down regulated in the analysis. Red color indicates a observed/predicted
activation and green color indicates a observed/predicted inhibition of the molecule or complex of molecules. All interactions are based on
experimental evidence from the scientific literature. Arrow directions show which way the regulation is directed, if known. R: regulation; B:
binding; Br: binding regulated by target; RR: bidirectional regulation; Tg: target. The network was extracted from the MetaCore™ database
(Thomson Reuters). For details about observation/prediction state, see Additional files 2, 3, 4 and 5.
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except for a few pathways that seem to always be highly
regulated. The method also shows promising results in
the detection of pre- and prohapten activation as a
grouped class of chemical reactivity. However, it does
not distinguish between these two activation routes. In
the literature cinnamic alcohol is classified as a prohap-
ten [22,23], but recently it has been shown that cin-
namic alcohol autoxidize very rapidly [24], making the
older classifications uncertain. Therefore, further inves-
tigation into the use of methods for separation of these
two classes of chemical reactivity is needed. Especially
for prohaptens, it is also crucial to confirm purity levels
stated by suppliers as even small amounts of impurities
may change the reactivity patterns.It should be noted that all samples in this study are
collected at single concentrations and single time-
points. Most likely, the observed differences between
chemical groups depend in some instances on a varying
reactivity speed. As an example, investigations of tran-
scription factors, connecting directly to selected cell
cycle pathways, show that the activity level of the path-
way molecules can depend on temporal factors. Those
chemicals that did not show a great deal of activity in
the pathway did indeed have a relatively higher activity
level among the upstream regulators of these pathways.
Thus, there may be pathways that are more consistently
regulated than is observed in this study, although such
similarities may be masked by varying reactivity of the
chemical sensitizers.
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Next, the significantly predicted upstream regulators
were investigated. Figure 6 shows the known and experi-
mentally verified interactions in the dataset. The net-
work was manually built, in the IPA® software using
molecules predicted to be up or down regulated based
on analysis of the expression patterns of the nine chem-
ical reactivity groups studied. The molecular interactions
were studied in detail using the MetaCore™ software for
pathways analyses focusing on uni- or bidirectional
binding and regulation actions of the included mole-
cules. All interactions shown in Figure 6 have been ex-
perimentally verified elsewhere and are described in the
scientific literature. Several of the transcription regula-
tors included in the network bind to each other, e.g.
MYC and ANXA2, RB1 and E2f2 and NFkB and E2f2.
Central to the network of Figure 6 is a microRNA group
named let-7 (lethal-7). The de-regulation of let-7
miRNAs has previously been described in association to
cancer, where the let-7 family members act as tumor sup-
pressors acting e.g. through MYC and E2f2 [25]. Both
MYC and E2f2 were predicted to be down regulated by a
majority of the chemical reactivity groups in this study.
The microRNA group let-7 and specifically the member
let-7a-5p was predicted to be significantly activated in six
out of the nine groups, with very high activation scores
(z-score 2.6 to 6.6) and regulated with borderline detec-
tion in the three remaining groups (z-score 1.3 to 1.8 in
ProH, ProH + PreH and Add/El). This finding fits well
with the known down regulation of let-7 by MYC,
through binding of MYC to the transcription start site of
the let-7 g pri-miRNA [26]. let-7 is known to be active in
cell cycle regulation, DNA replication, cell division, apop-
tosis and development [27]. In the current study, cell
cycle, apoptosis, and nucleotide metabolism pathways
were found to be down-regulated. This situation is com-
parable to many forms of cancer, in which low levels of
let-7 have been observed, giving rise to loss of cell cycle
control. In our case, down regulation of cell cycle func-
tions is evident for the majority of the chemical reactivity
groups studied, while let-7 was predicted to be up
regulated. In a review by Hou et al. [28], let-7 RNAs
were described as heavily down regulated by environ-
mental chemicals, cigarette smoke and up-regulated by
others, such as hexahydro-1,3,5-triazine (RDX). let-7 up-
regulation has also been demonstrated in skin samples
from psoriasis patients compared to healthy controls
[29], suggesting these microRNAs to be key players in
skin pathogenesis. Two other, specific, microRNAs were
also predicted to be significantly regulated namely let-7a-
5p and mir-483-3p. We propose that these microRNAs
may have similar functions, as described above, in skin,
when chemically challenged. For details about molecular
interactions found see Additional file 5.let-7 is known to inhibit a number of molecules:
ABCC10, BACH1, BLIMP1 (PRDI-BF1), Bax, CCR7,
Dicer, EZH2, HMGA2, HMGI/Y, HOXA9, IL-6, NAV1.9,
PGHD, SOCS1, UHRF2, and MYC that are all found reg-
ulated in the data set. BCL2L1 and DICER1 were found
to be up-regulated while all other were down-regulated.
Among the transcription regulators MYC and let-7
miRNAs are known to bind and interact bi-directionally.
Furthermore, let-7 is regulated by a number of other mole-
cules, several of which were seen regulated in the present
analysis, namely PPARA, DROSHA, XPO5, and KDM5B.
Finally, let-7 binds to the predicted activated transcription
regulator TGFB1.
The ascribed biological functions of the upstream reg-
ulators were extracted from the IPA® database. Many
of them have known relevant functions in skin and
skin disorders, including CDKN1A, CDKN2A, CCND1,
CSF2, MYC, PTEN, SMARCB1, TGM2, TP53, E2F2, Ret-
inoic acid, NFkB, TGFB1, TNF-α and let-7. Of particular
interest, CSF2, NFkB, TGFB1, TNF-α and TP53 have been
associated with hypersensitivity and allergy reactions.
BRD4, CCND1, CDKN2A, E2F1, FOXM1, HGF, KDM5B.
MYB, MYC, NFkB2, PTEN, RB1, RBL1/2, SMARCB1,
TGFB1, TP53, Butyric acid and let-7 are all regulators of
the cell cycle. In addition, a majority of these molecules are
associated with various forms of cancer, as many carcin-
omas act through disruption of the cell cycle. Of interest,
many of the predicted elements, such as CDKN2A, E2F1,
E2F2, MYC, SMARCB1, TP53, TGM2, TNF-α, Retinoic
acid, NFkB and TGFB1 are known regulators or members
of the Aryl Hydrocarbon Receptor signaling pathway.
The NFkB complex was also predicted to be activated
in this study. This extensively studied nucleic protein
has a wide range of functions. Of interest to this study
is mainly its involvement in pathways of Xenobiotics
Metabolism, Production of Nitric Oxide and Reactive
Oxygen Species in Macrophages and Toll like receptor
signaling. NFkB showed a heterogeneous pattern, with
up regulation in four groups (MA + Add/El, MA, SN2
and ProH) and down regulation in one (ProH + PreH).
This may be a relevant finding given the role this mol-
ecule plays in epithelial cells where it on one hand main-
tains immunological homeostasis and on the other
induces inflammatory processes [30]. NFkB has been
shown to be able both to activate and inhibit inflamma-
tory pathways in skin [31], a finding that might explain
the mixed pattern seen in this study.
Implications of the results
Activation of MUTZ-3 cells with skin sensitizers resulted
in regulation of a number of previously known, as well as
novel, canonical pathways. The 33 most significantly regu-
lated pathways were studied in detail. After stratification
of sensitizing chemicals into chemical reactivity groups, it
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regulated molecules within such pathways were linked to
the sensitizing potency of the stimulatory agent. For in-
stance, cell cycle associated pathways were engaged grad-
ually in correlation with the sensitizing potency of the
chemicals used for cell stimulations. These observations
can be utilized when designing tools for assessment of
sensitizing potency of chemicals in predictive assays. Cur-
rently, the primary prediction call obtained from GARD is
binary, i.e. compounds are classified as sensitizers or non-
sensitizers. However, this readout can now for the first
time be complemented with a potency call based on mech-
anistic information obtained through pathway analysis.
While implementation of such classifications are not
straight-forward, similar attempts have been done within
cancer research, where pathway activity has successfully
been associated with subtypes of cancer and progression of
disease [32-34].
Oxidative stress related pathways are also in the group
of highly engaged pathways. These do not correlate with
potency to the same extent that cell cycle pathways
do. For example, the NRF2-mediated oxidative stress
response pathway shows a higher engagement by less
potent chemical groups compared to more potent ones.
This may be a consideration when studying more clin-
ically relevant allergens, as these are rarely in the strong
to extreme but rather in the week to medium range of
potency.
Pathways regulating metabolism and biosynthesis
processes constitute the third large group of canonical
pathways identified to be regulated in skin sensitization.
These pathways are regulated to a lesser extent but
still show the same pattern as seen in the cell cycling
pathways.
No canonical pathway was unanimously regulated
within each data set. The importance of this fact becomes
apparent when considering the design of various pro-
posed tests for animal-free assessment of sensitization,
which today are mainly based on analysis of single bio-
markers. It is evident that excessively simplistic tests lack
the power to accurately assess compounds as sensitizers
or non-sensitizers, if the target chemical domain is wide.
Recognition of the specific subtype of chemicals to be
tested based on reactive mechanism or otherwise, will be
crucial in order to train and configure predictive models
accurately.
Conclusions
In the present transcriptional profiling study, we have
shown that skin sensitizers trigger a large number of sig-
naling and metabolic pathways in MUTZ-3 cells. Among
these, we found examples of well-known pathways, as
well as pathways previously not described in relation
to chemical sensitization. Importantly, a majority of thepathways described show a clear correlation with both
chemical reactivity and sensitizing potency.
The strongest correlation between pathway usage and
potency is found in the cell cycle, nucleotide metabolism
and cancer pathways. As these groupings are obviously
rather arbitrary it is probably more correct to say that
functions involving cell cycle regulation and cell cycle
control both in healthy and diseased conditions correlate
very well with chemical potency. Nucleotide metabolism
is tightly connected to the cell cycle and consequently a
down regulation of nucleotide metabolism in parallel to
a down regulation of cell cycle functions is expected.
The apoptosis pathway Aryl Hydrocarbon Receptor sig-
naling is a novel finding with regard to potency predic-
tion. This pathway is among the highly regulated ones
but still shows a decrease in activity with decrease in
potency.
Finally, transcription regulation of the sensitization
process was investigated, by prediction of activation and
inhibition of upstream regulators. A network of regula-
tory elements that seemed to be generally involved was
identified. These seemed to be centered on the tran-
scription regulator MYC and the miRNA let-7.
The presented results have implications for the design
of predictive in vitro test for assessment of sensitization
potency. Few chemicals appear to induce identical re-
sponses in vitro, indicating that excessively simplistic
assays will fail to correctly classify unknown samples.
Subdivisions among sensitizers, by reactive domain or
otherwise, should be considered with caution and
predictive models should be trained accordingly. In
brief, we demonstrate for the first time that genomic
approaches contain valuable mechanistic information
associated with potency assessment of chemicals, which
is in line with the current demand of evidence based
toxicology.
Additional files
Additional file 1: Table of gene involvement shown per reactivity
group and per pathway, used for Figure 3. For each pathway
described in Figure 3 the exact numbers of molecules involved are given in
this table. No distinction is made between up or down regulated molecules.
Additional file 2: Table of upstream regulators predicted to be up
or down regulated in the IPA® analysis. Predictions were based on
expression data from the nine chemical reactivity groups studied.
Additional file 3: NRF2 Oxidative Stress Pathway map for Michael
addition or 1,4-Addition to a/b unsaturated carbonyl reactive
chemicals. The pathway map shows the NRF2 Oxidative Stress Pathway
with expression data from the 1000 most significant genes regulated by
MA. Red shows up regulation and green down regulation of a given
molecule. The less significantly regulated molecules were not shown in
this figure, indicated here as white molecule symbols.
Additional file 4: A detailed list of molecules in the Aryl
Hydrocarbon Receptor (AHR) signaling pathway. The file shows all
the molecules included in the AHR signaling pathway, as defined by IPA®.
Common identifiers are included to enable analysis in any software.
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http://www.biomedcentral.com/2050-6511/15/5Additional file 5: All upstream regulators identified in pathway
analysis in IPA®. This file contains the complete result from the
prediction analysis of the expression patterns seen in the nine data sets,
one from each chemical reactivity group studied. The upstream regulators
were predicted from the pattern of up or down regulated target molecules.
Significance of finding is given as z-scores for each upstream regulator and
an attached predicted activation status shows if the molecule is predicted to
be up or down regulated. Molecules measured on the microarrays (observed)
are recognized by a value in the fold change column.
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